Personal tools

Coexpression cluster:C1514: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C1514_Neutrophils_Adipocyte_tenocyte_chorionic_Hair_Preadipocyte_Mesenchymal |id=C1514 }}")
 
No edit summary
Line 2: Line 2:
|full_id=C1514_Neutrophils_Adipocyte_tenocyte_chorionic_Hair_Preadipocyte_Mesenchymal
|full_id=C1514_Neutrophils_Adipocyte_tenocyte_chorionic_Hair_Preadipocyte_Mesenchymal
|id=C1514
|id=C1514
|ontology_enrichment_celltype=CL:0000055!6.75e-23!180;CL:0000057!4.41e-15!75;CL:0002620!4.49e-11!23;CL:0000048!6.54e-10!430;CL:0000680!9.13e-10!57;CL:0000056!9.13e-10!57;CL:0000355!9.13e-10!57;CL:0000723!4.39e-09!436;CL:0000187!2.41e-08!54;CL:0000034!4.75e-08!444;CL:0000393!6.46e-08!60;CL:0000211!6.46e-08!60;CL:0000136!8.16e-08!15;CL:0000183!4.96e-07!59
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0000914!1.30e-13!83;UBERON:0002329!1.30e-13!83;UBERON:0003077!1.30e-13!83;UBERON:0003059!1.30e-13!83;UBERON:0007282!1.30e-13!83;UBERON:0009618!1.30e-13!83;UBERON:0007285!1.30e-13!83;UBERON:0004290!2.39e-11!70;UBERON:0002199!2.44e-09!45;UBERON:0002416!2.44e-09!45;UBERON:0002385!6.81e-09!63;UBERON:0001015!6.81e-09!63;UBERON:0000383!6.81e-09!63;UBERON:0000486!7.80e-09!82;UBERON:0001134!8.41e-09!61;UBERON:0002036!8.41e-09!61;UBERON:0003082!8.41e-09!61;UBERON:0003102!1.30e-08!95;UBERON:0002097!2.53e-07!40;UBERON:0005256!9.91e-07!143
}}
}}

Revision as of 14:12, 21 May 2012


Full id: C1514_Neutrophils_Adipocyte_tenocyte_chorionic_Hair_Preadipocyte_Mesenchymal



Phase1 CAGE Peaks

Hg19::chr3:154834468..154834481,+p@chr3:154834468..154834481
+
Hg19::chr3:154862149..154862165,+p@chr3:154862149..154862165
+
Hg19::chr3:154898430..154898445,+p@chr3:154898430..154898445
+
Hg19::chr3:154899435..154899447,+p@chr3:154899435..154899447
+
Hg19::chr3:154899522..154899536,+p@chr3:154899522..154899536
+
Hg19::chr3:154899644..154899672,+p@chr3:154899644..154899672
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
non-terminally differentiated cell6.75e-23180
fibroblast4.41e-1575
skin fibroblast4.49e-1123
multi fate stem cell6.54e-10430
muscle precursor cell9.13e-1057
myoblast9.13e-1057
multi-potent skeletal muscle stem cell9.13e-1057
somatic stem cell4.39e-09436
muscle cell2.41e-0854
stem cell4.75e-08444
electrically responsive cell6.46e-0860
electrically active cell6.46e-0860
fat cell8.16e-0815
contractile cell4.96e-0759
Uber Anatomy
Ontology termp-valuen
somite1.30e-1383
paraxial mesoderm1.30e-1383
presomitic mesoderm1.30e-1383
presumptive segmental plate1.30e-1383
trunk paraxial mesoderm1.30e-1383
presumptive paraxial mesoderm1.30e-1383
dermomyotome2.39e-1170
integument2.44e-0945
integumental system2.44e-0945
muscle tissue6.81e-0963
musculature6.81e-0963
musculature of body6.81e-0963
multilaminar epithelium7.80e-0982
skeletal muscle tissue8.41e-0961
striated muscle tissue8.41e-0961
myotome8.41e-0961
surface structure1.30e-0895
skin of body2.53e-0740
trunk mesenchyme9.91e-07143


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.